Nebivolol prevents remodeling in a rat myocardial infarction model: an echocardiographic study

被引:0
作者
Mercanoglu, Gueldem Olguner [1 ]
Pamukcu, Burak [2 ]
Safran, Nurhas [3 ]
Mercanoglu, Fehmi [2 ]
Fici, Francesco [4 ]
Gungor, Mehmet [5 ]
机构
[1] Yeditepe Univ, Fac Pharm, Dept Pharmacol, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Med, Dept Cardiol, Istanbul, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Microbiol, Istanbul, Turkey
[4] Univ Naples 2, Excellence Res Ctr Cardiovasc Dis, Dept Expt Med, Naples, Italy
[5] Istanbul Univ, Istanbul Fac Med, Dept Pharmacol & Clin Pharmacol, Istanbul, Turkey
关键词
Myocardial infarction; ventricular remodeling; nebivolol; echocardiography; nitric oxide; peroxynitrite; left ventricular function; NITRIC-OXIDE; CARVEDILOL; METOPROLOL; HEART; PERFORMANCE; GEOMETRY; THERAPY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Ventricular remodeling (VR) which develops after myocardial infarction (MI) plays an important role in progressive left ventricular dysfunction. We aimed to investigate the role of nebivolol treatment on VR after a MI in a rat ischemia-reperfusion model. Methods: Rats were divided into 3 groups of 12 each: sham operated (sham-control), MI-induced (MI-control) and nebivolol treated (MI-nebivolol). Left ventricular (LV) diameters, volumes, and diastolic filling parameters were evaluated by echocardiography. On the 28(th) day, after recording the systemic and LV pressures and determining the plasma nitric oxide (NO) and peroxynitrite (ONOO-) levels, animals were sacrificed and heart, body and LV weights (HW, BW, LVW) were measured and infarct sizes were determined. Results were evaluated statistically by ANOVA for repeated measurements 3x3 factorial design with post-hoc Bonferroni test. Results: After MI, while VR (an increase in LV diameters and volumes associated with a decrease in EF, FS and posterior wall thickness change (LWPc) was significant in MI-control rats (p<0.05 for; all comparisons) these changes were significantly less in MI-nebivolol group (p=0.08 and p=0.06 for EF and FS respectively). LV end diastolic pres-sure (LVEDP) was lower (p<0.005) and Delta +/- dp/dt's (p<0.05) were higher in MI-nebivolol group compared to MI-control animals. Although infarct sizes were similar in MI-induced groups (p=0.79); LVW/HW and HW/BW's were significantly greater in the MI-control group compared to sham-control (p<0.01 for all comparisons), these changes were not statistically significant in MI-nebivolol group. The increase in plasma NO and ONOO- levels were also prevented with nebivolol. Conclusion: Nebivolol therapy reduced the effects of VR in rats after MI. These beneficial effects were not related to its heart rate and blood pressure reducing effects. Nitric oxide regulatory action of this compound may contribute these beneficial effects on VR developed after MI. (Anadolu Kardiyol Derg 2010; 10: 18-27)
引用
收藏
页码:18 / 27
页数:10
相关论文
共 40 条
[1]  
[Anonymous], 1986, LANCET, V2, P57
[2]  
Antman EM, 2001, BRAUNWALDS HEART DIS, P1184
[3]   NITRIC-OXIDE ATTENUATES CARDIAC MYOCYTE CONTRACTION [J].
BRADY, AJB ;
WARREN, JB ;
POOLEWILSON, PA ;
WILLIAMS, TJ ;
HARDING, SE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01) :H176-H182
[4]   A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload [J].
Cantor, EJF ;
Babick, AP ;
Vasanji, Z ;
Dhalla, NS ;
Netticadan, T .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (05) :777-786
[5]   Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients [J].
Celik, T ;
Iyisoy, A ;
Kursaklioglu, H ;
Kardesoglu, E ;
Kilic, S ;
Turhan, H ;
Yilmaz, MI ;
Ozcan, O ;
Yaman, H ;
Isik, E ;
Fici, F .
JOURNAL OF HYPERTENSION, 2006, 24 (03) :591-596
[6]  
Chlopicki S, 2002, J PHYSIOL PHARMACOL, V53, P615
[7]   Endothelial β3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation β-blocker nebivolol [J].
Dessy, C ;
Saliez, J ;
Ghisdal, P ;
Daneau, G ;
Lobysheva, II ;
Frérart, F ;
Belge, C ;
Jnaoui, K ;
Noirhomme, P ;
Feron, O ;
Balligand, JL .
CIRCULATION, 2005, 112 (08) :1198-1205
[8]   Rat models of hypertension, cardiac hypertrophy and failure [J].
Doggrell, SA ;
Brown, L .
CARDIOVASCULAR RESEARCH, 1998, 39 (01) :89-105
[9]   Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study [J].
Edes, I ;
Gasior, Z ;
Wita, K .
EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (04) :631-639
[10]  
Feigenbaum H., 2005, FEIGENBAUMS ECHOCARD, V6th, P138